Breast Cancer Clinical Trials in Shantou, Guangdong
5 recruitingShantou, Guangdong, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Breast Cancer
Shantou Central Hospital64 enrolled1 locationNCT05728268
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 3
A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.642 enrolled25 locationsNCT07003074
Recruiting
Not Applicable
Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
Breast Cancer
Shantou Central Hospital132 enrolled1 locationNCT06495034
Recruiting
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
Breast CancerLymph Node Metastasis
Shantou Central Hospital2,400 enrolled1 locationNCT06001528